CANCER SCIENCE INSTITUTE OF SINGAPORE

Organization name
CANCER SCIENCE INSTITUTE OF SINGAPORE


Results 161-180 of 1943 (Search time: 0.012 seconds).

Issue DateTitleAuthor(s)
1612011The slow-releasing Hydrogen Sulfide donor, GYY4137, exhibits novel anti-cancer effects in vitro and in vivoLee, Z.W.; Zhou, J. ; Chen, C.-S.; Zhao, Y. ; Tan, C.-H. ; Li, L.; Moore, P.K.; Deng, L.-W.
16219-Jan-2023The Singapore National Precision Medicine StrategyWong E; Bertin N; Hebrard M; Tirado-Magallanes R ; Bellis C; Lim WK ; Chua CY ; Tong PML; Chua R ; Mak K; Lim TM ; Cheong WY; Thien KE; Goh KT; Chai JF ; Lee J ; Sung JJ; Wong TY ; Chin CWL ; Gluckman PD ; Goh LL; Ban KHK ; Tan TW ; Sim X ; Cheng CY ; Davila S ; Karnani N ; Leong KP; Liu J ; Prabhakar S; Maurer-Stroh S ; Verma CS ; Krishnaswamy P; Goh RSM ; Chia I; Ho C; Low D; Virabhak S ; Yong J ; Zheng W ; Seow SW ; Seck YK; Koh M; Chambers JC; Tai ES ; Tan P. ; SG10K_Health Consortium
1631-Feb-2020The RUNX1 Enhancer Element eR1: A Versatile Marker for Adult Stem CellsChuang, Linda Shyue Huey; Osato, Motomi ; Ito, Yoshiaki
1642015The RUNX family: Developmental regulators in cancerIto Y; Bae S.-C; Chuang L.S.H 
1651-May-2023The role of tumor-derived extracellular vesicles containing noncoding RNAs in mediating immune cell function and its implications from bench to bedsideLiu, CG; Chen, J; Goh, RMWJ ; Liu, YX; Wang, L ; Ma, Z
16619-Aug-2016THE ROLE OF TREFOIL FACTOR 3 IN MEDIATING RESISTANCE TOWARDS HER2-TARGETED DRUGS IN BREAST CANCERCHONG QING YUN
167Nov-2011The role of the tumor suppressor p53 pathway in the cellular DNA damage response to zinc oxide nanoparticlesNg, K.W.; Khoo, S.P.K.; Heng, B.C.; Setyawati, M.I.; Tan, E.C.; Zhao, X.; Xiong, S.; Fang, W. ; Leong, D.T. ; Loo, J.S.C.
168Nov-2011The role of the tumor suppressor p53 pathway in the cellular DNA damage response to zinc oxide nanoparticlesNg, K.W.; Khoo, S.P.K.; Heng, B.C.; Setyawati, M.I.; Tan, E.C.; Zhao, X.; Xiong, S.; Fang, W. ; Leong, D.T. ; Loo, J.S.C.
1692018The role of signal transducer and activator of transcription 3 (STAT3) and its targeted inhibition in hematological malignanciesArora, L; Kumar, A.P ; Arfuso, F; Chng, W.J ; Sethi, G 
1702-Aug-2023THE ROLE OF RNA HELICASES IN REGULATING RNA EDITOME AND RNA-INDUCED IMMUNITY IN CANCERLARRY NG TZE HIANG
1712017The role of resveratrol in cancer therapyKo, J.-H; Sethi, G ; Um, J.-Y; Shanmugam, M.K ; Arfuso, F; Kumar, A.P ; Bishayee, A; Ahn, K.S
1727-Aug-2018THE ROLE OF PROTEIN ARGININE METHYLTRANSFERASE 5 IN HEMATOPOIESISTAN QIANCHENG DARREN
1732019The role of prep1 in the regulation of mesenchymal stromal cellsMaroni, G. ; Panetta, D.; Luongo, R.; Krishnan, I.; La Rosa, F.; Campani, D.; Salvadori, P.; Iozzo, P.; Blasi, F.; Penkov, D.; Levantini, E.; Magli, M.C.
174Jan-2010The role of monoclonal antibody in combination with first-line chemotherapy in Asian patients with advanced non-small cell lung cancerCho, B.C.; Kim, J.H.; Soo, R.A. ; Yang, C.-H.
1752019The role of GRHL2 and epigenetic remodeling in epithelial–mesenchymal plasticity in ovarian cancer cellsChung, V.Y. ; Tan, T.Z. ; Ye, J. ; Huang, R.-L.; Lai, H.-C.; Kappei, D. ; Wollmann, H.; Guccione, E.; Huang, R.Y.-J. 
17618-Aug-2017THE ROLE OF ARID1A IN GASTRIC TUMORIGENESIS AND TUMOR DEVELOPMENTHU LONGYU
1777-Nov-2010The role of allogeneic SCT in primary myelofibrosis: A British Society for Blood and Marrow Transplantation studyStewart, W.A. ; Pearce, R.; Kirkland, K.E.; Bloor, A.; Thomson, K.; Apperley, J.; McQuaker, G.; Marks, D.I.; Craddock, C.; McCann, S.; Russell, N.; Cook, G.; Kottaridis, P.D.
1782-Aug-2023THE ROLE OF ADAR1 AND RNA EDITING IN REGULATING IMMUNE HOMEOSTASIS IN THE LIVERGAN WEI LIANG
1792008The relevance of molecular diagnostics in the practice of surgical pathologyNg, S.-B. ; Lee, V. ; Salto-Tellez, M. ; Das, K. 
1802016The relationship between self-reported habitual exercise and visual field defect progression: A retrospective cohort studyYokota, S; Takihara, Y ; Kimura, K; Takamura, Y; Inatani, M